ISTA Pharmaceuticals, Inc. (ISTA) announced that financial guidance for the full year 2010, projecting net revenue of about $147 to $165 million.
In addition, ISTA anticipates reporting its first profitable year in 2010, with earnings per share for the full year expected to be at least $0.02, excluding any mark-to-market adjustments relating to warrants.
On average, three analysts polled by Thomson Reuters currently expect the company to earn $0.16 per share, on revenues of $147.90 million for fiscal 2010. Analysts estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com